Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2850

TDMS Study 05069-08 Pathology Tables

                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE


NTP Experiment-Test: 05069-08                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 03/13/95
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18


                                                           CORE STUDY


       Facility:  TSI Mason Research

       Chemical CAS #:  147-47-7

       Lock Date:  08/21/92

       Cage Range:  All

       Reasons For Removal:    25019 Moribund Sacrifice                25020 Natural Death
                               25026 Other                             25021 Terminal Sacrifice

       Removal Date Range:     All

       Treatment Groups:       Include All






























a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60           60                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                19           10            9            9                                     
    Natural Death                                     12           19           19           19                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                19           21           22           22                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (49)         (47)         (48)         (47)                                   
      Erosion                                                       1 (2%)                                                          
   Intestine Large, Rectum                            (49)         (47)         (47)         (46)                                   
      Erosion                                                       1 (2%)                                                          
   Intestine Large, Cecum                             (48)         (43)         (42)         (45)                                   
      Edema                                                                      1 (2%)                                             
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Acute                                           1 (2%)                    1 (2%)                                
      Ulcer                                                                      1 (2%)                                             
   Intestine Small, Jejunum                           (49)         (41)         (44)         (44)                                   
      Inflammation, Chronic                            1 (2%)                                                                       
      Ulcer                                            1 (2%)                                                                       
   Intestine Small, Ileum                             (45)         (40)         (42)         (40)                                   
      Inflammation, Chronic                                         1 (3%)                                                          
      Metaplasia, Osseous                                           1 (3%)                                                          
      Ulcer                                                         1 (3%)                                                          
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      3 (6%)       1 (2%)       2 (4%)       2 (4%)                                
      Basophilic Focus                                35 (70%)     36 (72%)     32 (64%)     30 (60%)                               
      Clear Cell Focus                                 7 (14%)      7 (14%)      9 (18%)     12 (24%)                               
      Congestion                                                                 1 (2%)                                             
      Eosinophilic Focus                              12 (24%)     16 (32%)     17 (34%)     14 (28%)                               
      Hematopoietic Cell Proliferation                 3 (6%)                                 1 (2%)                                
      Hepatodiaphragmatic Nodule                      11 (22%)      5 (10%)      6 (12%)     16 (32%)                               
      Inflammation, Chronic                                                                   3 (6%)                                
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Mixed Cell Focus                                10 (20%)      6 (12%)      9 (18%)     11 (22%)                               
      Regeneration                                                  1 (2%)       2 (4%)                                             
      Centrilobular, Atrophy                                        1 (2%)                                                          
      Centrilobular, Necrosis                          1 (2%)                                                                       
      Centrilobular, Vacuolization Cytoplasmic        11 (22%)      5 (10%)      6 (12%)      9 (18%)                               
      Midzonal, Vacuolization Cytoplasmic                                                     1 (2%)                                
      Periportal, Vacuolization Cytoplasmic            1 (2%)       1 (2%)                                                          
      Serosa, Inflammation, Acute                                                             1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Serosa, Necrosis                                                                        1 (2%)                                
   Mesentery                                          (8)          (8)          (4)          (3)                                    
      Inflammation, Chronic                                         1 (13%)      1 (25%)                                            
      Metaplasia, Osseous                                                        1 (25%)                                            
      Fat, Necrosis                                    6 (75%)      7 (88%)      2 (50%)      2 (67%)                               
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                            1 (2%)                    1 (2%)                                             
      Metaplasia, Hepatocyte                                                                  1 (2%)                                
      Acinus, Atrophy                                 19 (38%)     15 (30%)     14 (28%)     14 (28%)                               
      Acinus, Hyperplasia                                                                     1 (2%)                                
      Artery, Thrombosis                               1 (2%)                                                                       
      Duct, Cyst                                                    1 (2%)                    1 (2%)                                
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)       1 (2%)                    1 (2%)                                
      Duct, Cyst                                       1 (2%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (49)         (50)                                   
      Diverticulum                                                               1 (2%)                                             
      Hyperplasia, Squamous                           13 (26%)     10 (20%)      6 (12%)      7 (14%)                               
      Inflammation, Chronic                            9 (18%)      6 (12%)      5 (10%)      5 (10%)                               
      Perforation                                                                             1 (2%)                                
      Ulcer                                           10 (20%)      8 (16%)      5 (10%)      5 (10%)                               
   Stomach, Glandular                                 (50)         (50)         (50)         (49)                                   
      Erosion                                         13 (26%)      6 (12%)      6 (12%)      7 (14%)                               
      Hyperplasia                                                                1 (2%)                                             
      Mineralization                                   1 (2%)                                                                       
      Ulcer                                                         1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  41 (82%)     46 (92%)     43 (86%)     43 (86%)                               
      Mineralization                                   1 (2%)                                                                       
      Atrium, Thrombosis                               3 (6%)       2 (4%)                    2 (4%)                                
      Valve, Thrombosis                                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                                 1 (2%)                                
      Atrophy                                          1 (2%)                                                                       
      Degeneration                                                                            1 (2%)                                
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia                                      7 (14%)      4 (8%)       2 (4%)       5 (10%)                               
      Necrosis                                         1 (2%)       1 (2%)                    1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Vacuolization Cytoplasmic                       13 (26%)     12 (24%)      8 (16%)      8 (16%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      8 (16%)      3 (6%)       3 (6%)       3 (6%)                                
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
      Metaplasia, Hepatocyte                                                     1 (2%)       1 (2%)                                
   Parathyroid Gland                                  (44)         (50)         (49)         (48)                                   
      Hyperplasia                                      1 (2%)                                 1 (2%)                                
   Pituitary Gland                                    (49)         (50)         (50)         (50)                                   
      Craniopharyngeal Duct, Pars Intermedia,                                                                                       
          Hyperplasia                                               1 (2%)                                                          
      Pars Distalis, Angiectasis                       9 (18%)     13 (26%)      7 (14%)     11 (22%)                               
      Pars Distalis, Cyst                              6 (12%)      2 (4%)                    1 (2%)                                
      Pars Distalis, Hyperplasia                      11 (22%)     13 (26%)     16 (32%)     11 (22%)                               
      Rathke's Cleft, Cyst                                                                    1 (2%)                                
      Rathke's Cleft, Hemorrhage                                                              1 (2%)                                
   Thyroid Gland                                      (49)         (50)         (48)         (49)                                   
      Hyperplasia                                                                             1 (2%)                                
      C-Cell, Hyperplasia                              9 (18%)     12 (24%)     11 (23%)      4 (8%)                                
      Follicular Cell, Hyperplasia                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (49)         (46)         (45)         (49)                                   
      Cyst                                             3 (6%)       2 (4%)       1 (2%)       2 (4%)                                
      Hyperplasia                                      3 (6%)       1 (2%)                                                          
      Inflammation, Acute                              1 (2%)       2 (4%)       2 (4%)       1 (2%)                                
      Inflammation, Chronic                                                      2 (4%)                                             
      Metaplasia, Squamous                                                       1 (2%)                                             
   Ovary                                              (50)         (50)         (50)         (50)                                   
      Cyst                                             8 (16%)      2 (4%)       5 (10%)      7 (14%)                               
      Bilateral, Cyst                                  1 (2%)                                 2 (4%)                                
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Cyst                                                          1 (2%)                    1 (2%)                                
      Hyperplasia, Cystic                                                                     1 (2%)                                
      Inflammation, Chronic                            1 (2%)                                                                       
   Vagina                                                          (1)          (2)                                                 
      Inflammation, Chronic                                                      1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (49)         (50)         (50)                                   
      Hyperplasia, Reticulum Cell                                                1 (2%)                                             
      Myelofibrosis                                                 1 (2%)                    1 (2%)                                
   Lymph Node                                         (13)         (10)         (7)          (1)                                    
      Bronchial, Depletion Lymphoid                                 1 (10%)                                                         
      Lumbar, Depletion Lymphoid                                    1 (10%)                                                         
      Mediastinal, Congestion                          1 (8%)                                                                       
      Mediastinal, Ectasia                                          1 (10%)                                                         
      Mediastinal, Hemorrhage                                       3 (30%)                                                         
      Mediastinal, Infiltration Cellular, Plasma                                                                                    
          Cell                                                      1 (10%)      1 (14%)                                            
      Pancreatic, Ectasia                                           1 (10%)                                                         
      Pancreatic, Erythrophagocytosis                  1 (8%)                                                                       
      Pancreatic, Pigmentation                                      1 (10%)                                                         
      Renal, Hemorrhage                                1 (8%)                    1 (14%)                                            
   Lymph Node, Mandibular                             (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       3 (6%)       1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Infiltration Cellular, Plasma Cell               2 (4%)       1 (2%)                    1 (2%)                                
   Lymph Node, Mesenteric                             (50)         (49)         (50)         (50)                                   
      Ectasia                                          1 (2%)       1 (2%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hemorrhage                                       1 (2%)                                 1 (2%)                                
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Infiltration Cellular, Polymorphonuclear                      1 (2%)                                                          
      Inflammation, Acute                                                                     1 (2%)                                
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)                                                                       
      Fibrosis                                         6 (12%)      4 (8%)       3 (6%)                                             
      Hematopoietic Cell Proliferation                 3 (6%)       5 (10%)      6 (12%)      4 (8%)                                
      Pigmentation                                     1 (2%)       1 (2%)                                                          
      Capsule, Necrosis                                                                       1 (2%)                                
   Thymus                                             (47)         (50)         (49)         (50)                                   
      Cyst                                                          1 (2%)                    1 (2%)                                
      Ectopic Parathyroid Gland                        2 (4%)                                 1 (2%)                                
      Metaplasia, Osseous                                                                     1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (48)         (49)         (49)         (50)                                   
      Galactocele                                      2 (4%)      10 (20%)      3 (6%)       5 (10%)                               
      Inflammation, Chronic Active                                  1 (2%)                                                          
   Skin                                               (50)         (50)         (50)         (50)                                   
      Acanthosis                                       2 (4%)       1 (2%)       5 (10%)      3 (6%)                                
      Inflammation, Acute                              1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Inflammation, Chronic                            6 (12%)     10 (20%)      8 (16%)      8 (16%)                               
      Necrosis                                                                   1 (2%)                                             
      Necrosis, Chronic                                                                       1 (2%)                                
      Ulcer                                            1 (2%)                                                                       
      Skin, Site of Application, Acanthosis                         1 (2%)       9 (18%)     22 (44%)                               
      Skin, Site of Application, Hyperkeratosis                     1 (2%)       7 (14%)      1 (2%)                                
      Skin, Site of Application, Inflammation,                                                                                      
           Chronic                                                  1 (2%)       2 (4%)       2 (4%)                                
      Subcutaneous Tissue, Foreign Body                                          1 (2%)                                             
      Subcutaneous Tissue, Inflammation, Chronic       2 (4%)       3 (6%)       3 (6%)       1 (2%)                                
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                       1 (2%)                                                                       
      Subcutaneous Tissue, Skin, Site of                                                                                            
          Application, Inflammation, Chronic           2 (4%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                           2 (4%)                                                                       
      Hyperostosis                                                               1 (2%)                                             
      Cranium, Fracture                                             1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)       1 (2%)       2 (4%)       1 (2%)                                
   Peripheral Nerve                                                             (1)                                                 
      Axon, Degeneration                                                         1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                                    1 (2%)       1 (2%)                                             
      Edema                                                                      1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Infiltration Cellular, Histiocyte                5 (10%)      5 (10%)      2 (4%)       3 (6%)                                
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic                            3 (6%)       1 (2%)                    3 (6%)                                
      Inflammation, Chronic Active                                               1 (2%)                                             
      Inflammation, Granulomatous                                                             1 (2%)                                
      Alveolar Epithelium, Hyperplasia                              1 (2%)       3 (6%)       2 (4%)                                
      Alveolus, Edema                                               1 (2%)                                                          
      Capillary, Thrombosis                            1 (2%)                                                                       
      Serosa, Fibrosis                                              1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
   Nose                                               (50)         (50)         (50)         (49)                                   
      Foreign Body                                     2 (4%)       2 (4%)       2 (4%)       4 (8%)                                
      Fungus                                           2 (4%)       3 (6%)       2 (4%)       2 (4%)                                
      Inflammation, Chronic                                                                   1 (2%)                                
      Inflammation, Chronic Active                     4 (8%)       6 (12%)      3 (6%)       7 (14%)                               
      Thrombosis                                                    3 (6%)       3 (6%)       1 (2%)                                
      Nasolacrimal Duct, Inflammation, Acute           1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                          (2)          (3)                                    
      Iris, Synechia                                                             1 (50%)                                            
      Lens, Cataract                                                             2 (100%)     3 (100%)                              
      Posterior Chamber, Hemorrhage                                                           1 (33%)                               
      Retina, Atrophy                                                            1 (50%)                                            
      Retina, Degeneration                                                       1 (50%)      2 (67%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Accumulation, Hyaline Droplet                    4 (8%)                                                                       
      Hydronephrosis                                                1 (2%)                                                          
      Infarct                                          1 (2%)                                                                       
      Inflammation, Acute                                                        1 (2%)                                             
      Nephropathy, Chronic                            49 (98%)     45 (90%)     48 (96%)     49 (98%)                               
      Pigmentation                                                  2 (4%)       1 (2%)       1 (2%)                                
      Papilla, Necrosis                                             1 (2%)                                                          
      Renal Tubule, Hyperplasia                                                  1 (2%)                                             
   Urinary Bladder                                    (50)         (48)         (49)         (50)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60           60                                     
  Early Deaths                                                                                                                      
    Natural Death                                     21           26           25           23                                     
    Moribund Sacrifice                                24           22           20           26                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                 5            2            4            1                                     
  Other                                                                          1                                                  
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (47)         (47)         (42)         (44)                                   
      Inflammation, Acute                                                                     1 (2%)                                
      Ulcer                                                                                   1 (2%)                                
   Intestine Large, Rectum                            (47)         (49)         (49)         (45)                                   
      Angiectasis                                                   1 (2%)                                                          
      Inflammation, Acute                                           2 (4%)                                                          
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Necrosis                                                      1 (2%)                                                          
   Intestine Large, Cecum                             (42)         (44)         (36)         (39)                                   
      Dilatation                                       1 (2%)                                                                       
      Erosion                                                       1 (2%)                                                          
      Inflammation, Acute                              2 (5%)       7 (16%)                   4 (10%)                               
      Necrosis                                         1 (2%)       1 (2%)                    1 (3%)                                
      Ulcer                                                         3 (7%)                    2 (5%)                                
   Intestine Small, Duodenum                          (50)         (50)         (46)         (48)                                   
      Diverticulum                                                               1 (2%)                                             
      Erosion                                                       2 (4%)                    1 (2%)                                
      Inflammation, Chronic Active                                                            2 (4%)                                
      Ulcer                                                                                   1 (2%)                                
   Intestine Small, Jejunum                           (46)         (45)         (42)         (39)                                   
      Inflammation, Acute                              1 (2%)                                                                       
   Intestine Small, Ileum                             (40)         (37)         (34)         (37)                                   
      Diverticulum                                     1 (3%)                                                                       
      Fibrosis                                                                                1 (3%)                                
      Inflammation, Chronic                            1 (3%)       1 (3%)       1 (3%)                                             
      Metaplasia, Osseous                              1 (3%)                                                                       
      Necrosis                                                                                1 (3%)                                
      Ulcer                                                         1 (3%)                                                          
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      6 (12%)      5 (10%)      1 (2%)       1 (2%)                                
      Basophilic Focus                                 8 (16%)      4 (8%)       3 (6%)       4 (8%)                                
      Clear Cell Focus                                 5 (10%)      3 (6%)       3 (6%)       3 (6%)                                
      Congestion                                       1 (2%)                                 1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Degeneration, Cystic                             3 (6%)       6 (12%)      7 (14%)      2 (4%)                                
      Eosinophilic Focus                                            1 (2%)                    1 (2%)                                
      Hepatodiaphragmatic Nodule                       8 (16%)      7 (14%)      8 (16%)      4 (8%)                                
      Hyperplasia                                                   1 (2%)                                                          
      Infiltration Cellular, Histiocyte                                                       1 (2%)                                
      Inflammation, Chronic                            1 (2%)                                 3 (6%)                                
      Leukocytosis                                                  1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Mixed Cell Focus                                              1 (2%)                    4 (8%)                                
      Necrosis                                         4 (8%)                    2 (4%)       3 (6%)                                
      Regeneration                                                  1 (2%)                    1 (2%)                                
      Centrilobular, Necrosis                          3 (6%)       1 (2%)       2 (4%)       4 (8%)                                
      Centrilobular, Vacuolization Cytoplasmic        12 (24%)      6 (12%)      8 (16%)      7 (14%)                               
      Periportal, Vacuolization Cytoplasmic            4 (8%)                    2 (4%)       4 (8%)                                
      Serosa, Fibrosis                                                           1 (2%)                                             
      Serosa, Necrosis                                                           1 (2%)                                             
   Mesentery                                          (10)         (3)          (3)          (4)                                    
      Hemorrhage                                       2 (20%)                                2 (50%)                               
      Inflammation, Chronic                                                      1 (33%)                                            
      Inflammation, Granulomatous                      1 (10%)                                                                      
      Artery, Angiectasis                                                                     1 (25%)                               
      Fat, Necrosis                                    6 (60%)      2 (67%)      1 (33%)      1 (25%)                               
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Cytoplasmic Alteration                                        1 (2%)                                                          
      Inflammation, Acute                                           1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)                    1 (2%)                                             
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Acinus, Atrophy                                 25 (50%)     21 (42%)     20 (40%)     23 (46%)                               
      Acinus, Hyperplasia                              2 (4%)       3 (6%)       4 (8%)       6 (12%)                               
      Artery, Angiectasis                                           2 (4%)                    2 (4%)                                
      Artery, Inflammation, Chronic                    1 (2%)                    1 (2%)                                             
      Artery, Mineralization                                        1 (2%)                    1 (2%)                                
   Salivary Glands                                    (49)         (50)         (50)         (50)                                   
      Fibrosis                                                                   1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (50)         (49)                                   
      Erosion                                                                    1 (2%)                                             
      Foreign Body                                                               1 (2%)                                             
      Hyperplasia, Squamous                           29 (58%)     34 (68%)     31 (62%)     28 (57%)                               
      Inflammation, Acute                                                        2 (4%)                                             
      Inflammation, Chronic                           17 (34%)     14 (28%)     20 (40%)     14 (29%)                               
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                   1 (2%)       1 (2%)       5 (10%)      2 (4%)                                
      Perforation                                      4 (8%)       5 (10%)      7 (14%)      4 (8%)                                
      Ulcer                                           20 (40%)     25 (50%)     16 (32%)     15 (31%)                               
   Stomach, Glandular                                 (50)         (50)         (50)         (49)                                   
      Erosion                                         13 (26%)     22 (44%)     22 (44%)     17 (35%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Infiltration Cellular, Lymphocyte                1 (2%)                                 1 (2%)                                
      Inflammation, Chronic                            3 (6%)       1 (2%)       1 (2%)                                             
      Metaplasia, Squamous                             1 (2%)                                                                       
      Mineralization                                  15 (30%)     19 (38%)     20 (40%)     16 (33%)                               
      Ulcer                                            2 (4%)       2 (4%)       3 (6%)       3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                                    (1)                       (1)                                    
      Aorta, Mineralization                                                                   1 (100%)                              
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  47 (94%)     48 (96%)     48 (96%)     44 (88%)                               
      Inflammation, Acute                                                                     2 (4%)                                
      Mineralization                                  10 (20%)     15 (30%)     13 (26%)      9 (18%)                               
      Thrombosis                                                                              1 (2%)                                
      Atrium, Inflammation, Acute                      2 (4%)                                                                       
      Atrium, Thrombosis                               4 (8%)       5 (10%)      9 (18%)      3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Angiectasis                                                                2 (4%)                                             
      Cytoplasmic Alteration                                                     2 (4%)                                             
      Hemorrhage                                       2 (4%)       2 (4%)       3 (6%)       1 (2%)                                
      Hyperplasia                                      2 (4%)       2 (4%)       2 (4%)       5 (10%)                               
      Hypertrophy                                                   1 (2%)                                                          
      Inflammation, Acute                                           1 (2%)                                                          
      Necrosis                                         2 (4%)                                                                       
      Vacuolization Cytoplasmic                        9 (18%)     11 (22%)     11 (22%)      9 (18%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     28 (56%)     33 (66%)     30 (60%)     23 (46%)                               
      Mineralization                                                             1 (2%)                                             
   Islets, Pancreatic                                 (50)         (50)         (49)         (50)                                   
      Hyperplasia                                      4 (8%)       1 (2%)                    1 (2%)                                
   Parathyroid Gland                                  (48)         (49)         (46)         (49)                                   
      Hyperplasia                                     18 (38%)     21 (43%)     23 (50%)     23 (47%)                               
      Mineralization                                                1 (2%)       1 (2%)                                             
   Pituitary Gland                                    (49)         (50)         (50)         (49)                                   
      Angiectasis                                                   1 (2%)                    1 (2%)                                
      Mineralization                                                1 (2%)                                                          
      Craniopharyngeal Duct, Hyperplasia                            1 (2%)                                                          
      Craniopharyngeal Duct, Pars Nervosa,                                                                                          
          Hyperplasia                                               1 (2%)                                                          
      Pars Distalis, Angiectasis                       4 (8%)       2 (4%)       4 (8%)       1 (2%)                                
      Pars Distalis, Cyst                              3 (6%)       4 (8%)       6 (12%)      8 (16%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Hemorrhage                                                               1 (2%)                                
      Pars Distalis, Hyperplasia                      11 (22%)     14 (28%)     12 (24%)     14 (29%)                               
      Pars Distalis, Pigmentation                      1 (2%)                    2 (4%)                                             
      Pars Intermedia, Angiectasis                                                            1 (2%)                                
      Pars Intermedia, Cyst                            2 (4%)                    1 (2%)                                             
      Pars Nervosa, Cyst                               1 (2%)       1 (2%)                    1 (2%)                                
      Rathke's Cleft, Cyst                                          1 (2%)                    2 (4%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Cyst                                                                       1 (2%)                                             
      Mineralization                                                1 (2%)                                                          
      C-Cell, Hyperplasia                              4 (8%)       7 (14%)      2 (4%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (1)                                                                           
      Mediastinum, Necrosis                            1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Atrophy                                                                    1 (2%)                                             
      Granuloma Sperm                                                            2 (4%)                                             
      Inflammation, Acute                                           1 (2%)                                                          
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Necrosis                                                      1 (2%)                                                          
   Penis                                              (6)          (10)         (2)          (2)                                    
      Foreign Body                                     1 (17%)                                                                      
      Inflammation, Acute                              2 (33%)      5 (50%)      1 (50%)      1 (50%)                               
      Inflammation, Chronic Active                     1 (17%)                                                                      
      Mineralization                                                1 (10%)                                                         
   Preputial Gland                                    (50)         (49)         (49)         (49)                                   
      Abscess                                                                    1 (2%)                                             
      Cyst                                                          1 (2%)       2 (4%)                                             
      Fibrosis                                         1 (2%)                                                                       
      Hyperplasia                                                   1 (2%)       1 (2%)                                             
      Inflammation, Acute                              5 (10%)      2 (4%)       5 (10%)      8 (16%)                               
      Inflammation, Chronic                            4 (8%)                                 1 (2%)                                
      Inflammation, Chronic Active                                                            1 (2%)                                
      Inflammation, Granulomatous                      1 (2%)                                                                       
   Prostate                                           (50)         (50)         (50)         (49)                                   
      Developmental Malformation                                                 1 (2%)                                             
      Inflammation, Acute                              1 (2%)       1 (2%)                                                          
      Inflammation, Chronic                           23 (46%)     28 (56%)     22 (44%)     24 (49%)                               
      Inflammation, Chronic Active                     1 (2%)                                 1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Inflammation, Acute                                           1 (2%)                                                          
      Inflammation, Chronic                                                      2 (4%)                                             
      Inflammation, Chronic Active                     1 (2%)                                 1 (2%)                                
      Mineralization                                                2 (4%)       2 (4%)                                             
   Testes                                             (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Mineralization                                   2 (4%)       1 (2%)       1 (2%)       2 (4%)                                
      Arteriole, Inflammation, Chronic                                           1 (2%)                                             
      Interstitial Cell, Hyperplasia                  27 (54%)     22 (44%)     25 (50%)     31 (62%)                               
      Seminiferous Tubule, Degeneration               21 (42%)     25 (50%)     26 (52%)     23 (46%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Hypoplasia                                       4 (8%)                                 2 (4%)                                
      Myelofibrosis                                    5 (10%)                                                                      
      Necrosis                                         1 (2%)                                 1 (2%)                                
   Lymph Node                                         (19)         (15)         (6)          (9)                                    
      Mediastinal, Angiectasis                         2 (11%)                                                                      
      Mediastinal, Congestion                          1 (5%)                                 1 (11%)                               
      Mediastinal, Ectasia                             1 (5%)       2 (13%)                                                         
      Mediastinal, Erythrophagocytosis                 2 (11%)      2 (13%)                                                         
      Mediastinal, Hemorrhage                          1 (5%)       3 (20%)      1 (17%)      1 (11%)                               
      Mediastinal, Infiltration Cellular, Plasma                                                                                    
          Cell                                         1 (5%)                                                                       
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                   1 (5%)                                                                       
      Mediastinal, Pigmentation                                                               1 (11%)                               
      Pancreatic, Angiectasis                          1 (5%)       1 (7%)                                                          
      Pancreatic, Congestion                           1 (5%)                                                                       
      Pancreatic, Ectasia                                           1 (7%)                                                          
      Pancreatic, Hemorrhage                           2 (11%)      2 (13%)                                                         
      Pancreatic, Hyperplasia, Lymphoid                             1 (7%)                                                          
      Pancreatic, Infiltration Cellular, Plasma                                                                                     
          Cell                                                                                1 (11%)                               
      Pancreatic, Necrosis                             1 (5%)                                                                       
      Renal, Ectasia                                   1 (5%)                                                                       
      Renal, Hemorrhage                                                                       1 (11%)                               
   Lymph Node, Mandibular                             (49)         (50)         (50)         (50)                                   
      Ectasia                                                                    1 (2%)                                             
      Erythrophagocytosis                                           1 (2%)                                                          
      Hemorrhage                                       1 (2%)                    1 (2%)       1 (2%)                                
      Hyperplasia, Lymphoid                            2 (4%)                                                                       
      Infiltration Cellular, Plasma Cell               5 (10%)                                2 (4%)                                
      Infiltration Cellular, Histiocyte                             1 (2%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Necrosis                                         1 (2%)                                                                       
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (49)                                   
      Angiectasis                                      2 (4%)       1 (2%)                    2 (4%)                                
      Congestion                                       1 (2%)                                                                       
      Depletion Lymphoid                               1 (2%)       1 (2%)                    1 (2%)                                
      Ectasia                                          5 (10%)      3 (6%)       6 (12%)      3 (6%)                                
      Erythrophagocytosis                              2 (4%)       2 (4%)                    2 (4%)                                
      Hemorrhage                                       3 (6%)       5 (10%)      2 (4%)       2 (4%)                                
      Hyperplasia, Lymphoid                            1 (2%)                    1 (2%)                                             
      Infiltration Cellular, Polymorphonuclear         1 (2%)                                                                       
      Infiltration Cellular, Histiocyte                             1 (2%)                                                          
      Inflammation, Acute                                           1 (2%)                                                          
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Fibrosis                                        11 (22%)     12 (24%)     12 (24%)     13 (26%)                               
      Hematopoietic Cell Proliferation                 2 (4%)       7 (14%)      6 (12%)      2 (4%)                                
      Necrosis                                                                                2 (4%)                                
      Pigmentation                                     2 (4%)                                                                       
      Capsule, Necrosis                                             2 (4%)       4 (8%)                                             
      Lymphoid Follicle, Depletion Cellular                         1 (2%)                                                          
      Red Pulp, Thrombosis                             1 (2%)                                                                       
   Thymus                                             (45)         (44)         (49)         (46)                                   
      Angiectasis                                                   1 (2%)                                                          
      Ectopic Parathyroid Gland                                                  3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (42)         (42)         (45)         (40)                                   
      Galactocele                                     12 (29%)      5 (12%)      3 (7%)       2 (5%)                                
   Skin                                               (50)         (50)         (49)         (50)                                   
      Acanthosis                                       9 (18%)      5 (10%)      6 (12%)      7 (14%)                               
      Hyperkeratosis                                                1 (2%)       1 (2%)       5 (10%)                               
      Inflammation, Acute                              2 (4%)       2 (4%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic                                         2 (4%)       1 (2%)       1 (2%)                                
      Ulcer                                            1 (2%)       1 (2%)                    1 (2%)                                
      Skin, Site of Application, Acanthosis            1 (2%)       4 (8%)      14 (29%)     21 (42%)                               
      Skin, Site of Application, Cyst Epithelial                                                                                    
          Inclusion                                                 1 (2%)                                                          
      Skin, Site of Application, Hyperkeratosis        2 (4%)       2 (4%)       2 (4%)       3 (6%)                                
      Skin, Site of Application, Inflammation,                                                                                      
           Chronic                                                  3 (6%)                                                          
      Subcutaneous Tissue, Hemorrhage                                                         1 (2%)                                
      Subcutaneous Tissue, Inflammation, Acute         1 (2%)                                                                       
      Subcutaneous Tissue, Inflammation, Chronic       1 (2%)                                 1 (2%)                                
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                    1 (2%)                    1 (2%)                                
      Subcutaneous Tissue, Skin, Site of                                                                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
          Application, Fibrosis                        1 (2%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                          21 (42%)     24 (48%)     27 (54%)     25 (50%)                               
      Inflammation, Chronic                                                                   1 (2%)                                
      Osteomalacia                                                                            1 (2%)                                
      Mandible, Cyst                                                                          1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       4 (8%)       2 (4%)       3 (6%)       1 (2%)                                
      Inflammation, Acute                                                                     1 (2%)                                
      Cerebrum, Necrosis                                                                      1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)       1 (2%)                                                          
      Emphysema                                                                               2 (4%)                                
      Hemorrhage                                       7 (14%)      9 (18%)      5 (10%)      4 (8%)                                
      Infiltration Cellular, Histiocyte               10 (20%)     13 (26%)     15 (30%)     15 (30%)                               
      Inflammation, Acute                                           2 (4%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic                            3 (6%)                                 3 (6%)                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                   2 (4%)       7 (14%)      6 (12%)      6 (12%)                               
      Thrombosis                                                                              1 (2%)                                
      Alveolar Epithelium, Hyperplasia                              3 (6%)       1 (2%)       1 (2%)                                
      Alveolus, Edema                                  4 (8%)       3 (6%)       9 (18%)      5 (10%)                               
      Capillary, Thrombosis                                                      4 (8%)                                             
   Nose                                               (50)         (49)         (50)         (50)                                   
      Foreign Body                                    15 (30%)     11 (22%)      9 (18%)      9 (18%)                               
      Fungus                                          19 (38%)     21 (43%)     13 (26%)     10 (20%)                               
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Chronic Active                    26 (52%)     24 (49%)     22 (44%)     16 (32%)                               
      Thrombosis                                       2 (4%)                    1 (2%)                                             
      Ulcer                                            2 (4%)       4 (8%)                    2 (4%)                                
      Vein, Thrombosis                                 1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
NTP Experiment-Test: 05069-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE                           Date: 03/13/95  
Route: DERMAL,SOLUTION                                                                                            Time: 18:33:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      36 MG/KG     60 MG/KG     100                                       
                                                                                          MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (3)          (3)                                                 
      Anterior Chamber, Inflammation, Acute                         1 (33%)                                                         
      Choroid, Mineralization                                       1 (33%)                                                         
      Cornea, Inflammation, Acute                                   1 (33%)                                                         
      Iris, Synechia                                                             1 (33%)                                            
      Lens, Cataract                                   1 (100%)     3 (100%)     3 (100%)                                           
      Retina, Degeneration                                          2 (67%)      1 (33%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                            13 (26%)     10 (20%)     17 (34%)     20 (40%)                               
      Hydronephrosis                                   1 (2%)                                                                       
      Infarct                                          1 (2%)                                 1 (2%)                                
      Inflammation, Acute                                                                     2 (4%)                                
      Mineralization                                   3 (6%)       2 (4%)       5 (10%)      4 (8%)                                
      Nephropathy, Chronic                            50 (100%)    50 (100%)    49 (98%)     50 (100%)                              
      Pigmentation                                                  2 (4%)       1 (2%)                                             
      Cortex, Mineralization                                                     1 (2%)                                             
      Renal Tubule, Degeneration, Hyaline                                                     1 (2%)                                
      Renal Tubule, Hyperplasia                        2 (4%)                    6 (12%)      3 (6%)                                
      Vein, Thrombosis                                                           1 (2%)                                             
   Urinary Bladder                                    (49)         (50)         (50)         (48)                                   
      Calculus Gross Observation                       2 (4%)                                 1 (2%)                                
      Calculus Micro Observation Only                                                         1 (2%)                                
      Hemorrhage                                       1 (2%)                    1 (2%)       1 (2%)                                
      Inflammation, Acute                                           1 (2%)                    1 (2%)                                
      Inflammation, Chronic                            1 (2%)                    1 (2%)       1 (2%)                                
      Mineralization                                                1 (2%)                    1 (2%)                                
      Transitional Epithelium, Hyperplasia                                       1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   15                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------